يعرض 821 - 840 نتائج من 1,773 نتيجة بحث عن '(( 2 we decrease ) OR ( 10 ((peer decrease) OR (((nn decrease) OR (a decrease)))) ))', وقت الاستعلام: 0.20s تنقيح النتائج
  1. 821
  2. 822

    Repositioning for pressure injury prevention in adults. حسب Gillespie, Brigid M

    منشور في 2020
    "…Positioning regimens: four trials compared different tilt positions We pooled data from two trials (252 participants) that compared a 30° tilt with a 90° tilt (random-effects; I² = 69%). …"
    احصل على النص الكامل
    احصل على النص الكامل
  3. 823
  4. 824
  5. 825
  6. 826
  7. 827
  8. 828
  9. 829

    Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/B-catenin and AKT/GSK3B proliferative signaling حسب Chung, Jihyun

    منشور في 2019
    "…We show that PRMT5 stimulates WNT/B-CATENIN signaling through direct epigenetic silencing of pathway antagonists, AXIN2 and WIF1, and indirect activation of AKT/GSK3 signaling.PRMT5 inhibition with either shRNA-mediated knockdown or a specific small molecule PRMT5 inhibitor, CMP-5, not only leads to derepression of WNT antagonists and decreased levels of active phospho-AKT (Thr-450 and Ser-473) and inactive phospho- GSK3B (Ser-9) but also results in decreased transcription of WNT/B-CATENIN target genes, CYCLIN D1, c-MYC, and SURVIVIN, and enhanced lymphoma cell death. …"
    احصل على النص الكامل
    احصل على النص الكامل
  10. 830

    EFFECT OF ENDOPLASMIC RETICULUM STRESS MEDIATED BY HYPERGLYCEMIA ON BARRIER FUNCTION IN RETINAL CELLS حسب Saif, Atiya Ramadan

    منشور في 2016
    "…Methodology: In the present study, utilizing the HRMEC, we evaluated the effect of high glucose (30mM) on several ER stress signaling pathway genes (HSPA5, EIF2K3, and XBP1) at the mRNA expression level; the inflammatory cytokines (NFkB) at the mRNA level; the adhesion molecules (ICAM-1 and P-selectin) by flow cytometry. …"
    احصل على النص الكامل
  11. 831
  12. 832
  13. 833
  14. 834
  15. 835
  16. 836
  17. 837
  18. 838

    Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus حسب Dimitrios, Patoulias

    منشور في 2023
    "…They have demonstrated1 that empagliflozin treatment resulted in a significant decrease in pulse pressure (PP), mean arterial pressure (MAP) and cardiac workload, compared with placebo; at week 12, placebo-adjusted mean changes from baseline were − 2.5 mmHg for PP, − 2.2 mmHg for MAP and − 315 mmHg x beats per minute (bpm) for cardiac workload (p < 0.0001 for all). …"
    احصل على النص الكامل
    احصل على النص الكامل
    احصل على النص الكامل
  19. 839
  20. 840